FURIN and coronary atherosclerosis: Yakala et al. explored the impact of systemic furin inhibition on vascular remodeling and coronary atherosclerosis in hyperlipidemic Ldlr−/− mice using the irreversible furin inhibitor α-1-PDX (α1-antitrypsin Portland).